+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Can Fite Biofarma

CANFAMEX

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$3.81

-0.69-15.33%

At Close: -

$4.00

0.194.99%

After Hours: 4:54 PM EDT

15 minutes delayed

Can Fite Biofarma (CANF) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Can Fite Biofarma (AMEX:CANF) Stock

Can Fite Biofarma Stock (AMEX: CANF)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, July 17, 2024

EF Hutton Initiates Coverage On Can Fite Biof...
Benzinga Newsdesk

Thursday, July 11, 2024

Can-Fite Submits Application To FDA For Orpha...
Benzinga Newsdesk

Monday, July 01, 2024

Can-Fite Biopharma Announced That A Patient W...
Benzinga Newsdesk

Friday, June 28, 2024

Can-fite Biopharma Says Its Veterinary Partne...
Benzinga Newsdesk

Monday, June 24, 2024

Can-Fite Announces New Findings on Namodenoso...
Benzinga Newsdesk

Friday, June 14, 2024

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor

Wednesday, June 05, 2024

Can-Fite Biopharma Says Its Phase 3 Study For...
Benzinga Newsdesk

Thursday, May 09, 2024

HC Wainwright & Co. Reiterates Buy on Can Fit...
Benzinga Newsdesk
The FDA Has Granted Investigational New Drug ...
Benzinga Newsdesk

Monday, May 06, 2024

Can-Fite Received Notice of Allowance from th...
Benzinga Newsdesk

Thursday, April 25, 2024

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Can-Fite Biopharma Announced It Published An ...
Benzinga Newsdesk

Monday, April 15, 2024

Can-Fite's Namodenoson Featured in Biomedicin...
Benzinga Newsdesk

Wednesday, April 03, 2024

Can-Fite BioPharma Submits FDA with an IND Ap...
Benzinga Newsdesk

Thursday, March 28, 2024

Can Fite Biofarma: Q4 Earnings Insights
Benzinga Insights
Can Fite Biofarma FY GAAP EPS $(0.01), Same Y...
Benzinga Newsdesk

Wednesday, February 28, 2024

Can-Fite BioPharma Announced Notice Of Allowa...
Charles Gross

Tuesday, January 30, 2024

Can-Fite Expands the Out-Licensing Deal with ...
Benzinga Newsdesk

Wednesday, December 20, 2023

Can-Fite's Latest Innovation: Namodenoson Sho...
Benzinga Newsdesk

Monday, December 18, 2023

Can-Fite Receives Positive Response From FDA ...
Benzinga Newsdesk

Monday, December 04, 2023

Can-Fite Biopharma Has Completed The Design O...
Benzinga Newsdesk

Thursday, November 30, 2023

Recap: Can Fite Biofarma Q3 Earnings
Benzinga Insights
Can Fite Biofarma 9M Sales $588.00K Down From...
Benzinga Newsdesk

Tuesday, November 21, 2023

Can-Fite Biopharma Ltd Shares Resume Trade
Benzinga Newsdesk
Can-Fite Announces Exercise Of Warrants For A...
Benzinga Newsdesk
Can-Fite Biopharma Shares Halted, News Pendin...
Benzinga Newsdesk
Why Is Liver Cancer Focused Can-Fite BioPharma Stock Trading Higher Today?
Vandana Singh
Can-Fite Says A Patient Who Participated In P...
Benzinga Newsdesk

Thursday, October 26, 2023

Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
Charles Gross

Tuesday, October 24, 2023

Matson To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday
Lisa Levin
HC Wainwright & Co. Maintains Buy on Can Fite...
Benzinga Newsdesk

Monday, October 09, 2023

Can-Fite Signed Recently An Agreement With Fo...
Benzinga Newsdesk

Wednesday, September 27, 2023

Can-Fite Novel Approach for the Treatment of ...
Benzinga Newsdesk

Thursday, August 31, 2023

Can Fite BioPharma H1 EPS $(0.00), Same YoY, ...
Benzinga Newsdesk

Thursday, August 24, 2023

Can-Fite Signs Agreement With Fondazione Tele...
Benzinga Newsdesk

Friday, August 18, 2023

Can-Fite Submitted to FDA a Pediatric Plan to...
Benzinga Newsdesk

Thursday, June 29, 2023

Can-Fite Receives FDA Feedback With Respect T...
Benzinga Newsdesk

Tuesday, June 13, 2023

Can-Fite To Submit IND For Treatment Of Pancr...
Benzinga Newsdesk

Friday, June 02, 2023

HC Wainwright & Co. Reiterates Buy on Can Fit...
Benzinga Newsdesk

Thursday, June 01, 2023

Recap: Can Fite Biofarma Q1 Earnings
Benzinga Insights

Tuesday, May 30, 2023

Can-Fite's Study On Namodenoson's Inhibition ...
Benzinga Newsdesk

Tuesday, May 09, 2023

Can-Fite To Initiate Exploratory Phase 2 Tria...
Benzinga Newsdesk

Friday, May 05, 2023

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Can-Fite Announced Inhibition of Pancreatic Cancer by Namodenoson: Molecular Mechanism of Action Discovered by Can-Fite Scientists
Charles Gross

Monday, April 24, 2023

Can-Fite BioPharma Appointed Motti Farbstein ...
Benzinga Newsdesk

Tuesday, April 11, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights

Monday, April 10, 2023

Can-Fite Says EMA Gave Green Light For Piclid...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved